Mamoru Takada

815 total citations
26 papers, 393 citations indexed

About

Mamoru Takada is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mamoru Takada has authored 26 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mamoru Takada's work include Mitochondrial Function and Pathology (3 papers), Microtubule and mitosis dynamics (3 papers) and Cancer Treatment and Pharmacology (3 papers). Mamoru Takada is often cited by papers focused on Mitochondrial Function and Pathology (3 papers), Microtubule and mitosis dynamics (3 papers) and Cancer Treatment and Pharmacology (3 papers). Mamoru Takada collaborates with scholars based in Japan, United States and China. Mamoru Takada's co-authors include Qing Zhang, Giada Zurlo, Wenyi Wei, Jianping Guo, Cheng Fan, Lianxin Hu, Hiroyuki Inuzuka, Masayuki Ohtsuka, Ming Zhuang and Masaru Miyazaki and has published in prestigious journals such as The EMBO Journal, Cancer Research and Scientific Reports.

In The Last Decade

Mamoru Takada

23 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mamoru Takada Japan 11 215 110 105 64 45 26 393
Alexander C. Jordan United States 7 307 1.4× 87 0.8× 134 1.3× 60 0.9× 29 0.6× 10 453
Diego Alonso‐López Spain 9 351 1.6× 77 0.7× 92 0.9× 56 0.9× 34 0.8× 14 529
Dafei Xie China 13 365 1.7× 135 1.2× 119 1.1× 62 1.0× 28 0.6× 37 492
Dhruba Deb United States 8 310 1.4× 155 1.4× 171 1.6× 73 1.1× 41 0.9× 11 454
Peter Wang China 12 314 1.5× 100 0.9× 119 1.1× 42 0.7× 41 0.9× 30 408
Jarosław Suchański Poland 10 191 0.9× 58 0.5× 114 1.1× 49 0.8× 27 0.6× 15 378
Yvonne Li Canada 9 381 1.8× 92 0.8× 161 1.5× 50 0.8× 32 0.7× 15 525
Xiaoyong Luo China 9 214 1.0× 94 0.9× 64 0.6× 35 0.5× 34 0.8× 19 310
Mary Luz Uribe Spain 8 259 1.2× 81 0.7× 153 1.5× 104 1.6× 19 0.4× 14 513

Countries citing papers authored by Mamoru Takada

Since Specialization
Citations

This map shows the geographic impact of Mamoru Takada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mamoru Takada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mamoru Takada more than expected).

Fields of papers citing papers by Mamoru Takada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mamoru Takada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mamoru Takada. The network helps show where Mamoru Takada may publish in the future.

Co-authorship network of co-authors of Mamoru Takada

This figure shows the co-authorship network connecting the top 25 collaborators of Mamoru Takada. A scholar is included among the top collaborators of Mamoru Takada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mamoru Takada. Mamoru Takada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ganai, Sabha, et al.. (2025). Open chromatin-guided interpretable machine learning reveals cancer-specific chromatin features in cell-free DNA. Communications Biology. 8(1). 1554–1554.
2.
Takada, Mamoru, Hideyuki Yamada, Takeshi Nagashima, et al.. (2025). Inhibition of p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells. eLife. 13.
3.
Nagashima, Takeshi, et al.. (2023). A review of MRI (CT)/US fusion imaging in treatment of breast cancer. Journal of Medical Ultrasonics. 50(3). 367–373. 2 indexed citations
4.
Takada, Mamoru, Hideyuki Yamada, Hiroshi Fujimoto, et al.. (2023). Less necessity of adjuvant S‐1 treatment in non‐monarchE‐eligible patients. Cancer Medicine. 12(12). 13193–13203. 1 indexed citations
5.
Takada, Mamoru, Takeshi Suzuki, Ichiro Fukumoto, et al.. (2022). Infection control for COVID-19 in hospital examination room. Scientific Reports. 12(1). 18230–18230. 4 indexed citations
6.
Sasaki, Kosuke, Shigetsugu Takano, Katsunori Furukawa, et al.. (2021). C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 212–212. 16 indexed citations
7.
Takada, Mamoru, Gaku TANAKA, Hideyuki Hashimoto, et al.. (2021). Practical approach to prevent COVID-19 infection at breast cancer screening. Breast Cancer. 28(4). 969–976. 1 indexed citations
8.
Takano, Shigetsugu, Mamoru Satoh, Mamoru Takada, et al.. (2021). Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. Cellular Oncology. 44(4). 937–950. 41 indexed citations
9.
Liao, Chengheng, Yang Zhang, Cheng Fan, et al.. (2020). Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer. Cancer Discovery. 10(11). 1706–1721. 49 indexed citations
10.
Fujimoto, Hiroshi, Masayuki Kuroda, Yasuyuki Aoyagi, et al.. (2020). Anti-HER2 antibody therapy using gene-transduced adipocytes for HER2-positive breast cancer. Breast Cancer Research and Treatment. 180(3). 625–634. 1 indexed citations
11.
12.
Pestell, Richard G., Xi Chen, Jing Zhang, et al.. (2020). EglN2 associates with the NRF1‐PGC1α complex and controls mitochondrial function in breast cancer. UNC Libraries. 3 indexed citations
13.
Nakagawa, Ayako, Hiroshi Fujimoto, Takeshi Nagashima, et al.. (2019). Histological features of skin and subcutaneous tissue in patients with breast cancer who have received neoadjuvant chemotherapy and their relationship to post-treatment edema. Breast Cancer. 27(1). 77–84. 3 indexed citations
14.
15.
Takada, Mamoru, Weiguo Zhang, Aussie Suzuki, et al.. (2017). FBW7 Loss Promotes Chromosomal Instability and Tumorigenesis via Cyclin E1/CDK2–Mediated Phosphorylation of CENP-A. Cancer Research. 77(18). 4881–4893. 67 indexed citations
16.
Noda, K., T. Furukawa, T. Fujimoto, et al.. (2017). Recent progress and future plans of heavy-ion cancer radiotherapy with HIMAC. Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms. 406. 374–378. 14 indexed citations
17.
Zurlo, Giada, Jianping Guo, Mamoru Takada, Wenyi Wei, & Qing Zhang. (2016). New Insights into Protein Hydroxylation and Its Important Role in Human Diseases. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1866(2). 208–220. 45 indexed citations
18.
Zhang, Jing, Chengyang Wang, Xi Chen, et al.. (2015). EglN2 associates with the NRF 1‐ PGC 1α complex and controls mitochondrial function in breast cancer. The EMBO Journal. 34(23). 2953–2970. 59 indexed citations
19.
20.
Trabasso, Plı́nio, Francisco Hideo Aoki, Afonso Celso Vigorito, et al.. (2003). Phaeohyphomycosis Caused by Chaetomium Globosum in an Allogeneic Bone Marrow Transplant Recipient. Mycopathologia. 156(4). 309–312. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander C. Jordan Breakdown of academic impact, for papers by Diego Alonso‐López Breakdown of academic impact, for papers by Dafei Xie Breakdown of academic impact, for papers by Dhruba Deb Breakdown of academic impact, for papers by Peter Wang Breakdown of academic impact, for papers by Jarosław Suchański Breakdown of academic impact, for papers by Yvonne Li Breakdown of academic impact, for papers by Xiaoyong Luo Breakdown of academic impact, for papers by Mary Luz Uribe
Rankless by CCL
2026